357 related articles for article (PubMed ID: 35533891)
1. Effects of statins on specialized pro-resolving mediators: An additional pathway leading to resolution of inflammation.
Radbakhsh S; Katsiki N; Santos RD; Mikhailidis DP; Mantzoros CS; Sahebkar A
Metabolism; 2022 Jul; 132():155211. PubMed ID: 35533891
[TBL] [Abstract][Full Text] [Related]
2. Omega-3 (
Djuricic I; Calder PC
Nutrients; 2024 Mar; 16(7):. PubMed ID: 38612996
[TBL] [Abstract][Full Text] [Related]
3. E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: Preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition.
Serhan CN; Libreros S; Nshimiyimana R
Semin Immunol; 2022 Jan; 59():101597. PubMed ID: 35227568
[TBL] [Abstract][Full Text] [Related]
4. Specialized pro-resolving mediators as modulators of immune responses.
Julliard WA; Myo YPA; Perelas A; Jackson PD; Thatcher TH; Sime PJ
Semin Immunol; 2022 Jan; 59():101605. PubMed ID: 35660338
[TBL] [Abstract][Full Text] [Related]
5. Resolution of inflammation: Intervention strategies and future applications.
Panezai J; Van Dyke TE
Toxicol Appl Pharmacol; 2022 Aug; 449():116089. PubMed ID: 35644268
[TBL] [Abstract][Full Text] [Related]
6. Pro-resolving lipid mediators are leads for resolution physiology.
Serhan CN
Nature; 2014 Jun; 510(7503):92-101. PubMed ID: 24899309
[TBL] [Abstract][Full Text] [Related]
7. [Potential of specialized pro-resolving lipid mediators against rheumatic diseases].
Murakami K
Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):155-63. PubMed ID: 27320930
[TBL] [Abstract][Full Text] [Related]
8. [Anti-inflammatory pro-resolving derivatives of omega-3 and omega-6 polyunsaturated fatty acids].
Nowak JZ
Postepy Hig Med Dosw (Online); 2010 Mar; 64():115-32. PubMed ID: 20354260
[TBL] [Abstract][Full Text] [Related]
9. Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: Concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake.
Calder PC
Biochimie; 2020 Nov; 178():105-123. PubMed ID: 32860894
[TBL] [Abstract][Full Text] [Related]
10. Maresin 1 induces a novel pro-resolving phenotype in human platelets.
Lannan KL; Spinelli SL; Blumberg N; Phipps RP
J Thromb Haemost; 2017 Apr; 15(4):802-813. PubMed ID: 28079976
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 Lipid Mediators: Modulation of the M1/M2 Macrophage Phenotype and Its Protective Role in Chronic Liver Diseases.
Videla LA; Valenzuela R; Del Campo A; Zúñiga-Hernández J
Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958514
[TBL] [Abstract][Full Text] [Related]
12. Topical Administration of a Marine Oil Rich in Pro-Resolving Lipid Mediators Accelerates Wound Healing in Diabetic
Ontoria-Oviedo I; Amaro-Prellezo E; Castellano D; Venegas-Venegas E; González-Santos F; Ruiz-Saurí A; Pelacho B; Prósper F; Pérez Del Caz MD; Sepúlveda P
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077316
[TBL] [Abstract][Full Text] [Related]
13. Protectins: Their biosynthesis, metabolism and structure-functions.
Vidar Hansen T; Serhan CN
Biochem Pharmacol; 2022 Dec; 206():115330. PubMed ID: 36341938
[TBL] [Abstract][Full Text] [Related]
14. Regression of human coronary artery plaque is associated with a high ratio of (18-hydroxy-eicosapentaenoic acid + resolvin E1) to leukotriene B
Welty FK; Schulte F; Alfaddagh A; Elajami TK; Bistrian BR; Hardt M
FASEB J; 2021 Apr; 35(4):e21448. PubMed ID: 33749913
[TBL] [Abstract][Full Text] [Related]
15. Omega-3 Polyunsaturated Fatty Acids in Critical Illness: Anti-Inflammatory, Proresolving, or Both?
Molfino A; Amabile MI; Monti M; Muscaritoli M
Oxid Med Cell Longev; 2017; 2017():5987082. PubMed ID: 28694914
[TBL] [Abstract][Full Text] [Related]
16. Classes of Lipid Mediators and Their Effects on Vascular Inflammation in Atherosclerosis.
Lubrano V; Ndreu R; Balzan S
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675152
[TBL] [Abstract][Full Text] [Related]
17. Omacor and omega-3 fatty acids for treatment of coronary artery disease and the pleiotropic effects.
Kar S
Am J Ther; 2014; 21(1):56-66. PubMed ID: 21975796
[TBL] [Abstract][Full Text] [Related]
18. Resolvins as proresolving inflammatory mediators in cardiovascular disease.
Capó X; Martorell M; Busquets-Cortés C; Tejada S; Tur JA; Pons A; Sureda A
Eur J Med Chem; 2018 Jun; 153():123-130. PubMed ID: 28732558
[TBL] [Abstract][Full Text] [Related]
19. Specialized Pro-Resolving Lipid Mediators: Endogenous Roles and Pharmacological Activities in Infections.
Rasquel-Oliveira FS; Silva MDVD; Martelossi-Cebinelli G; Fattori V; Casagrande R; Verri WA
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446699
[TBL] [Abstract][Full Text] [Related]
20. n-3 Fatty acid supplementation and proresolving mediators of inflammation.
Barden AE; Mas E; Mori TA
Curr Opin Lipidol; 2016 Feb; 27(1):26-32. PubMed ID: 26655290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
